Bomar presents expanded bio-based oligomer portfolio at the ECS in Nuremberg, Germany
Bomar Specialties, one of the world's leading manufacturers of (meth)acrylate oligomers and specialty additives for UV/E…
Bomar Specialties, one of the world's leading manufacturers of (meth)acrylate oligomers and specialty additives for UV/E…
Horst Lindhofer, CEO of LINDIS Biotech and inventor of the trifunctional antibody technology succeeded in regaining the…
. Q1/2013: - Sales €4.9 billion (+11% at actual rates, +12% in constant currency) - EBIT[1] €696 million (+5% at actu…
Fresenius has decided to focus on its four established business segments Fresenius Medical Care, Fresenius Kabi, Freseni…
. - Q1-3/2012: - Sales1 €14.1 billion (+18% at actual rates, +12% in constant currency) - EBIT2 €2.2 billion (+19%…
. - Sales1 €9.2 billion (+17% at actual rates, +12% in constant currency) - EBIT2 €1.4 billion (+19% at actual rates,…
The Belgian Ministry of Social Affairs and Public Health has added the trifunctional antibody Removab® (catumaxomab) fro…
The European Commission has broadened the existing approval of Fresenius Biotech's antibody Removab® (catumaxomab) to tr…
TRION Pharma GmbH announces today that the results from two different studies demonstrate catumaxomab's capacity to acti…
. - Sales €11.8 billion, +13% at actual rates, +10% in constant currency - EBIT €1.8 billion, +19% at actual rates, +1…